Increasing Midwifery Students' Awareness of Breast and Gynecological Cancers Using Creative Drama Method

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-35
SponsorAtaturk University

About this trial

The aim of this study is to raise awareness among midwifery students, who are a part of the female population and a professional group that plays a critical role in the early diagnosis of these types of cancer, which are of critical importance for women's health, through an active education method such as drama.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being between the ages of 18-35,

Not having any health problems,

Agreeing to participate in the study,

Disqualifiers

Students who are under 18 or over 35 years old.

Students who do not voluntarily agree to participate in the study will not be included in the study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Creative Drama Education

    Other intervention

    This study is a pre-test/post-test controlled experimental design aimed at evaluating the effectiveness of creative drama education on awareness of breast and gynecological cancers. Students in the intervention group will receive creative drama-based training structured and implemented by the researcher. This training is designed to increase awareness of breast and gynecological cancers. The effectiveness of the training will be assessed by comparing participants' awareness levels before and after the intervention. For this purpose, the following data collection tools will be used: Personal Information Form Breast Cancer Awareness Scale Gynecological Cancers Awareness Scale The impact of the creative drama education on the awareness levels of students in the intervention group regarding breast and gynecological cancers will be evaluated through statistical analysis.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Control GroupNo intervention 0 interventions
Group B: Experimental GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Personel Information Form

The researcher will prepare a form based on literature information and will question the students' sociodemographic characteristics.

Time frame
Baseline
2

Gynecological Cancers Awareness Scale

To assess women's knowledge levels about gynecological cancers, Dal and Ertem developed the Gynecological Cancer Awareness Scale (GCAAS) in 2017. The scale consists of 41 questions and four subscales. 10. The scale can only be applied to women. The Cronbach's alpha value of the scale is 0.944. Questions 20-41 of the scale determine "Awareness of Routine Check-up and Perception of Serious Illness in Gynecological Cancers," and the Cronbach's alpha value of this subscale is 0.979. Questions three through 11 of the scale determine "Awareness of Gynecological Cancer Risks," and the Cronbach's alpha value of this subscale is 0.843. Questions 14-19 of the scale determine "Awareness of Prevention of Gynecological Cancers," and the Cronbach's alpha value is 0.778. The first and second questions of the scale, as well as the 12th and 13th questions, determine "Early Diagnosis and Information Awareness in Gynecological Cancers," and the Cronbach's Alpha value is 0.708.

Time frame
Baseline and up to 4 weeks
3

Breast Cancer Awareness Scale

The scale was developed by Rakkapao et al. (2016) for the early detection and prevention of breast cancer. It is easy to use and was designed as a self-report tool that allows researchers and practitioners to better understand women's breast cancer awareness levels. The original scale consists of five factors and 35 items. Adapted to our language by Altuntuğ et al. in 2021, the scale obtained a five-factor structure with 29 items. The subdimensions of the scale were found to have good internal consistency. The Cronbach's alpha internal consistency coefficients for the subdimensions of the scale were 0.87 for Knowledge of Risk Factors, 0.88 for Knowledge of Signs and Symptoms, 0.81 for Breast Cancer Prevention Attitudes, 0.78 for Barriers to Breast Screening, and 0.61 for Health Behavior Related to Breast Cancer Awareness.

Time frame
Baseline and up to 4 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: